HOME >> BIOLOGY >> NEWS
Study finds huge variability in vitamin E absorption

CORVALLIS A new study has found that cereal fortified with vitamin E has a very high rate of absorption into the bloodstream, whereas pills taken separately with the same food have inconsistent effects, and taking the supplements alone is largely useless.

The research was just published in the American Journal of Clinical Nutrition by scientists from the Linus Pauling Institute at Oregon State University.

The study points the way to more effective methods of taking this essential vitamin if people wish to supplement their diet, said Maret Traber, a professor with OSU's Linus Pauling Institute and national expert on vitamin E who recently served on federal panels to update the RDA for this vitamin.

As an antioxidant, vitamin E is one of the most commonly taken vitamin supplements in the world and included in virtually every multivitamin pill.

The research may explain, Traber said, why many past research studies done with vitamin E have varied findings. It's quite possible, she said, that the manner in which people took vitamin E supplements and the variation in its bioavailability from person to person have yielded widely inconsistent results about the value of this nutrient in heart disease and other degenerative diseases.

It may also be time to consider routine fortification of more foods with this vitamin, Traber said.

"For good reasons, Americans are increasingly moving towards low-fat diets," Traber said. "But average low-fat diets provide only about 5-8 international units a day of vitamin E. The recommended dietary allowance of vitamin E is 30 I.U. and it's possible that higher amounts than that are useful for optimal health. So we have to find ways to make sure everyone is getting enough of this nutrient."

A glitch, the researchers say, is that vitamin E is an oil, and people are now being told to use oils very sparingly. It can be found in nuts, oily fish, some vegetables and oils such as safflower, olive a
'"/>

Contact: Maret Traber
maret.traber@orst.edu
541-737-7977
Oregon State University
15-Jan-2004


Page: 1 2 3

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
Cached News: